Coronary Artery Disease
Eleven-Year Trends in Gender Differences of Treatments and Mortality in ST-Elevation Acute Myocardial Infarction in Northern Italy, 2000 to 2010

https://doi.org/10.1016/j.amjcard.2014.05.007Get rights and content

The aim of this study was to assess recent trends in hospital mortality and in the treatment techniques for patients with ST-segment elevation myocardial infarction according to gender. Data on hospitalizations for ST-segment elevation myocardial infarction from 2000 to 2010 were extracted from hospital discharge record databases (International Classification of Diseases, Ninth Revision, Clinical Modification, codes) in the Lombardy Region of Italy. The impact of female gender on in-hospital mortality was assessed by multivariable regression after adjusting for invasive approach use (i.e., coronary angiography, angioplasty or coronary artery bypass graft), age, and co-morbidities. A total of 89,562 patients, men (66.5%) and women (33.5%), were enrolled. The use of an invasive approach increased over time in both sexes although it was higher in men (from 54.9% in 2000 to 91.9% in 2010 in men; from 36.8% in 2000 to 72.0% in 2010 in women). This pattern was driven by the subgroup of patients aged ≥75 years, whereas differences between sexes were not observed in patients <65 years and were small in patients aged 65 to 74 years. In-hospital mortality presented a small decrease from 7.6% in 2000 to 6.2% in 2010 in men (p for trend = 0.004), whereas it remained higher and substantially constant over time in women (16.6% in 2000, 15.5% in 2010, p for trend = 0.09). At multivariable regression, female gender did not emerge as an independent predictor of mortality (p = 0.13). However, a significant gender-age interaction was found, with female gender being a significant predictor of increased mortality in patients aged ≥75 years (odds ratio [OR] 1.33) while predicting a reduced mortality in patients aged <75 years (OR 0.93, p for interaction <0.0001). The use of an invasive approach was an independent predictor of mortality (OR 0.23, p <0.0001), the magnitude of mortality reduction being higher in men than in women and in patients aged <75 years than in those aged ≥75 years. In conclusion, a weak temporal trend in mortality reduction is observed in men only, which is driven by patients aged ≥75 years. In-hospital mortality remains higher in women than in men, although female gender is not a significant predictor of mortality. Despite temporal increases in the use of an invasive approach, women are more often treated conservatively.

Section snippets

Methods

Cross-sectional data on all hospitalizations in Lombardy, a large Northern Italy region with >9.5 million subjects, during 2000 to 2010 were extracted from the regional hospital discharge record (HDR) database that covers all patient admissions to hospitals connected to the network of Italian National Health System. Briefly, all HDRs that belonged to major diagnostic category groups 1, 4, and 5, corresponding to neurologic, respiratory, and cardiovascular diseases, respectively, were extracted

Results

Between 2000 and 2010, a total of 89,562 patients, men (66.5%) and women (33.5%), have been admitted to the hospital. Baseline clinical characteristics according to sex are listed in Table 1. Briefly, women were older than men. The gap in mean admission patient age between sexes tended even to slightly increase over time. Women presented a higher prevalence of chronic renal failure and a lower prevalence of peripheral vascular disease and neoplasms (Table 1). First admission ward was more

Discussion

The main findings of this study that enrolled a broad unselected population of all-comer STEMI patients from a high-density population region are as follow: (1) despite improvement in the use of an invasive approach and in particular of PCI for the treatment of STEMI in both sexes over time, women still receive less frequently an invasive treatment and such gender-treatment gap persists over time; (2) a small decline in in-hospital mortality over time was observed in men only, while women

Disclosures

The authors have no conflict of interest to disclose.

References (25)

  • A.J. Lansky et al.

    Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial

    Circulation

    (2005)
  • S.C. Gan et al.

    Treatment of acute myocardial infarction and 30-day mortality among women and men

    N Engl J Med

    (2000)
  • Cited by (23)

    • SCAI Expert Consensus Statement on Sex-Specific Considerations in Myocardial Revascularization

      2022, Journal of the Society for Cardiovascular Angiography and Interventions
    • No significant gender difference in hospitalizations for acute coronary syndrome in Switzerland over the time period of 2001 to 2010

      2017, International Journal of Cardiology
      Citation Excerpt :

      Only the increase in the oldest age group (80 +) was significant and can be explained by the increasing practice of invasive procedures in the very elderly, parallel to the higher life expectancy. As shown in a large Italian cohort study consisting of 89.562 patients, the use of an invasive approach increased markedly over time in both sexes (from 54.9% in 2000 to 91.9% in 2010 in men; from 36.8% in 2000 to 72.0% in 2010 in women), while the change was mainly driven by the subgroup of patients aged 75 + years [41]. Similar in Switzerland, where the procedure of coronary angiography and PCI in ACS gained importance during the 1990s and rapidly replaced systemic thrombolysis.

    • Is female gender associated with worse outcome after ST elevation myocardial infarction?

      2017, Indian Heart Journal
      Citation Excerpt :

      There is also a debate on the independent role of gender in clinical outcomes of patients with STEMI.3,9,15 Although female gender was demonstrated as an independent risk factor for mortality after STEMI in some of the studies,7,9,15 others have reported no independent impact of gender on clinical outcomes.2,3 The fact that female patients are generally older with more concurrent diseases, higher mortality in females may result from other confounding factors, rather than gender itself.16,17

    View all citing articles on Scopus

    EC and GF equally contributed to this article.

    This study has been supported by a grant into the Strategic Research Finalized Ministerial Program by the Lombardy region (RFPS-2007-642981).

    See page 341 for disclosure information.

    View full text